Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comprehensive phenotyping and biological marker discovery.

Aaron B Kantor1

  • 1SurroMed, Inc, 2375 Garcia Ave, Mountain View, CA 94043, USA. akantor@surromed.com

Disease Markers
|October 5, 2002
PubMed
Summary

This study introduces a new bioanalytical platform for discovering disease biomarkers. It enables detailed patient sample analysis to improve disease characterization and treatment response assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic targeting of fibrin-microglia interactions ameliorates Alzheimer's disease-related hyperexcitability and brain network dysfunction.

bioRxiv : the preprint server for biology·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Development of a humanized anti-fibrin monoclonal antibody for the treatment of neuroinflammatory and retinal diseases.

Journal of neuroinflammation·2025
Same author

Regulation of the BCR signalosome by the class II peptide editor, H2-M, affects the development and repertoire of innate-like B cells.

Cell reports·2022
Same author

B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota.

eLife·2019

Area of Science:

  • Biomedical Science
  • Clinical Research
  • Biomarker Discovery

Background:

  • Significant unmet need exists for reliable biological markers to define disease characteristics, progression, and therapeutic efficacy.
  • Current methods often lack the comprehensive analysis required for precise patient stratification and personalized medicine.

Purpose of the Study:

  • To develop and implement an integrated bioanalytical platform and clinical research program.
  • To facilitate comprehensive differential phenotyping of patient samples for biomarker discovery.

Main Methods:

  • Utilizing a high-throughput, quantitative analytical platform.
  • Characterizing thousands of parameters from small-volume biological samples.
  • Analysis includes cell populations, cell-surface antigen density, soluble proteins, and low molecular weight biomolecules.

Main Results:

  • The platform enables detailed characterization of complex biological samples.
  • Facilitates the discovery of novel biomarkers for various disease aspects.
  • Demonstrates feasibility in a clinical research laboratory setting.

Conclusions:

  • The integrated bioanalytical platform addresses the critical need for advanced biomarker discovery.
  • This approach supports improved disease characterization, monitoring, and treatment selection.
  • The platform holds potential for advancing precision medicine initiatives.

Related Experiment Videos